Unlikely to cause harm — often a labeling or packaging issue.
Failed dissolution specifications.
| Brand name | TROKENDI XR |
| Generic name | TOPIRAMATE |
| Active ingredient(s) | TOPIRAMATE |
| Distributed by / for | Supernus Pharmaceuticals, Inc., Rockville, MD 20850 USA |
| NDC | 17772-102-30 |
| Full product label | Trokendi XR, (topiramate) extended-release capsules, 50 mg, 30 Capsules, Rx only, Manufactured by: Catalent Pharma Solutions, Winchester, KY 40391 USA, Manufactured for: Supernus Pharmaceuticals, Inc., Rockville, MD 20850 USA, NDC 17772-102-30. |
| Recalling firm | Supernus Pharmaceuticals, Inc. |
| Distribution | US Nationwide. |
| Quantity | 11304 bottles |
| Recall initiated | 2026-08-31 |
| Report date | 2026-09-09 |
| Recall completed | — |
| Recall number | D-0833-2026 |
| Classification | Class III |
| FDA status | Ongoing |
| Origin on file | Rockville MD United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗